Treatment, Medication & Supplement Directory

Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiver

Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.

Palladia / Toceranib · Prescription Drug · Targeted Therapy · Palladia · Dogs · After Targeted Therapy · During Targeted Therapy

Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy

Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…

Named profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.

Laverdia / Verdinexor · Prescription Drug · Targeted Therapy · Laverdia · Dogs · After Targeted Therapy · During Targeted Therapy

Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma

Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…

Veterinary team and caregiver reviewing an oncology treatment calendar for a dog

Chemotherapy · CHOP-style Chemotherapy · Dogs · After Chemotherapy · During Chemotherapy · Published Study · Veterinary Clinical Use

CHOP-Style Chemotherapy for Canine Lymphoma: Protocol Discussion Profile

CHOP is a family of veterinary lymphoma protocols built around cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine and prednisone. Exact sequence, dose and duration vary by oncology service and patient.

Veterinary team coordinating a medication schedule for a dog

Prescription Drug · Steroid / Prednisone Discussion · Dogs · During Chemotherapy · New Diagnosis · Palliative / Comfort Care · Published Study

Prednisone in Canine Cancer Care: A Timing and Safety Discussion

Prednisone is a prescription corticosteroid used in several veterinary cancer contexts, including components of lymphoma protocols and selected palliative plans. Its purpose, timing and taper must be defined…

Veterinary surgical planning scene with a calm dog and clinical team

Surgery / Procedure · Dogs · After Surgery · Before Surgery · Published Study · Veterinary Clinical Use · Veterinary Supervision Recommended

Splenectomy for a Splenic Mass: Diagnosis, Stabilization, and Next Steps

Removing the spleen may be diagnostic and therapeutic for selected splenic masses, but imaging cannot reliably determine benign versus malignant disease before pathology.

Calm dog receiving a monitored intravenous treatment in a veterinary clinic

Named profile Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma TherapyRepresentative category illustration – no product packaging is shown.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Tanovea · Dogs · After Chemotherapy · Before Chemotherapy

Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma Therapy

Rabacfosadine is a canine lymphoma drug whose current official label, patient selection, cumulative risks, and availability must be verified before use.

Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Dogs · After Chemotherapy · Before Chemotherapy · During Chemotherapy

Cisplatin in Dogs: Species-Specific and Kidney-Safety Boundary

Cisplatin is a platinum chemotherapy used only in carefully selected veterinary settings; it has major kidney, gastrointestinal, infusion, and species-specific hazards.

Prescription Drug · Targeted Therapy · Dogs · After Targeted Therapy · Before Targeted Therapy · During Targeted Therapy · Limited / Emerging Evidence

Imatinib in Canine Mast Cell Tumor Care: Extra-Label Evidence Review

Imatinib has published canine mast cell tumor experience but is not interchangeable with veterinary-labeled TKIs and requires specialist, legal, formulation, and evidence review.

Named profile Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell TumorsRepresentative category illustration – no product packaging is shown.

Prescription Drug · Targeted Therapy · Masivet · Dogs · After Targeted Therapy · Before Targeted Therapy · During Targeted Therapy

Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell Tumors

Masitinib is an oral canine TKI with an EMA veterinary authorization for a defined mast cell tumor setting; the current regional label governs eligibility and monitoring.

Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiver

Named profile Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic BiologicRepresentative category illustration – no product packaging is shown.

Immunotherapy · Oncept · Dogs · After Targeted Therapy · Before Targeted Therapy · During Targeted Therapy · Manufacturer Information

Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic Biologic

Oncept is a USDA-listed canine melanoma DNA biologic; license status, specialist access, intended setting, evidence limitations, and cost require current review.

Named profile Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor TherapyRepresentative category illustration – no product packaging is shown.

Prescription Drug · Targeted Therapy · Stelfonta · Dogs · After Targeted Therapy · During Targeted Therapy · Published Study

Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor Therapy

Stelfonta is an FDA-approved intratumoral treatment for narrowly defined canine mast cell tumors, with important current warnings about degranulation, wounds, pain, tissue loss, amputation, and death.